Ji-Yeon Kim
Ji-Yeon Kim
Seoul, South Korea4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Brain Metastasis Development Mechanism in BCBM Patients | Neoplasms by Site, Skin and Connective Tissue Diseases, brain disorder, breast cancer, breast disorder, breast neoplasm, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder, skin disorder | Recruiting | Not applicable | 2024-03-26 | NCT06330870 | |
| The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients. | HER2-positive Breast Cancer | Recruiting | Not applicable | 2024-03-26 | NCT06330012 | |
| LAG3 Expression in Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Not applicable | 2024-02-14 | NCT06259162 | |
| Exosome as the Prognostic and Predictive Biomarker in EBC Patients | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Not applicable | 2023-07-21 | NCT05955521 |